Showing 11-16 of 16 results for "".
- Impact of new first-in-class medical therapy in obstructive HCMhttps://pace-cme.org/topics/hypertrophic-cardiomyopathy/impact-of-new-first-in-class-medical-therapy-in-obstructive-hcm/17500/3' education - Apr. 3, 2022 - Joseph Cleveland, MD
- Cardiac myosin inhibitor is safe and effective in HCM in phase 2 trialhttps://pace-cme.org/congress-coverage/esc-heart-failure-2023/cardiac-myosin-inhibitor-is-safe-and-effective-in-hcm-in-phase-2-trial/17702/3' education - June 1, 2023 - Ahmad Masri, MD
- Cardiac myosin inhibitor sustainably reduces LVOT gradient in HCMhttps://pace-cme.org/topics/hypertrophic-cardiomyopathy/cardiac-myosin-inhibitor-sustainably-reduces-lvot-gradient-in-hcm/17504/3' education - Apr. 4, 2022 - Maya Guglin, MD, PhD
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
https://pace-cme.org/clinical-practice/cardiology/precision-medicine-in-obstructive-hcm-care-the-promise-of-cardiac-myosin-inhibitors/48692/Explore the promise of cardiac myosin inhibitors and how they are marking a paradigm shift in obstructive HCM Care.- First ESC guidelines on cardiomyopathies - managementhttps://pace-cme.org/congress-coverage/esc-congress-2023/first-esc-guidelines-on-cardiomyopathies-management/17738/5' education - Sep. 11, 2023 - Juan Pablo Kaski, MD
- First ESC guidelines on cardiomyopathies - diagnosishttps://pace-cme.org/congress-coverage/esc-congress-2023/first-esc-guidelines-on-cardiomyopathies-diagnosis/17742/5' education - Sep. 11, 2023 - Elena Arbelo, MD, PhD
- Previous
- Next